Publications by authors named "Shengui Tang"

Claim this Profile
F
FDA Approval of Palbociclib in Combination with Fulvestrant for the Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer.
Amanda J Walker, Suparna Wedam, Laleh Amiri-Kordestani, Erik Bloomquist, Shengui Tang

Clin Cancer Resยท October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis